Israel’s ELGAN (see here previously) has been awarded a $2.5 million grant by the European Innovation Council (EIC). It will help ELGAN clinically test its ELGN-GI oral formula for the treatment of intestinal malabsorption that prevents preterm infants from absorbing nutrients.

https://nocamels.com/2023/07/startup-treating-newborns-in-serious-condition-raises-2-5m/